Gary Shapiro

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-TGF-beta antibodies and their use
- Patent number 12,049,496
- Issue date Jul 30, 2024
- Sanofi
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TGF-beta antibodies and their use
- Patent number 11,242,384
- Issue date Feb 8, 2022
- Sanofi
- Gary Shapiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TGF-β antibodies and their use
- Patent number 10,766,955
- Issue date Sep 8, 2020
- Sanofi
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...
- Publication number 20240374721
- Publication date Nov 14, 2024
- Takeda Pharmaceutical Company Limited
- Chihiro Take
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED IMMUNE CELL THAT SPECIFICALLY TARGETS MESOTHELIN AND USE...
- Publication number 20240350627
- Publication date Oct 24, 2024
- Takeda Pharmaceutical Company Limited
- Chihiro Take
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING
- Publication number 20240226295
- Publication date Jul 11, 2024
- Takeda Pharmaceutical Company Limited
- Chantal KUHN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING
- Publication number 20240131158
- Publication date Apr 25, 2024
- Takeda Pharmaceutical Company Limited
- Chantal KUHN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND...
- Publication number 20240050473
- Publication date Feb 15, 2024
- Takeda Pharmaceutical Company Limited
- Gary SHAPIRO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND...
- Publication number 20240033359
- Publication date Feb 1, 2024
- Takeda Pharmaceutical Company Limited
- Gary SHAPIRO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND USE THEREOF
- Publication number 20230346938
- Publication date Nov 2, 2023
- Memorial Sloan-Kettering Cancer Center
- Judith FEUCHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF
- Publication number 20220363775
- Publication date Nov 17, 2022
- Memorial Sloan-Kettering Cancer Center
- Michel Sadelain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20220195026
- Publication date Jun 23, 2022
- SANOFI
- Gary Shapiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES AGAINST CANCER TARGETING CD38 AND TGF-BETA
- Publication number 20210155708
- Publication date May 27, 2021
- Francisco ADRIAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20200399358
- Publication date Dec 24, 2020
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20180244763
- Publication date Aug 30, 2018
- SANOFI
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gary Shapiro

Person

Patents Grantslast 30 patents

Anti-TGF-beta antibodies and their use

Anti-TGF-beta antibodies and their use

Anti-TGF-β antibodies and their use

Patents Applicationslast 30 patents

CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...

ENGINEERED IMMUNE CELL THAT SPECIFICALLY TARGETS MESOTHELIN AND USE...

CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING

CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING

COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND...

COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND...

CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND USE THEREOF

CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF

ANTI-TGF-BETA ANTIBODIES AND THEIR USE

COMBINATION THERAPIES AGAINST CANCER TARGETING CD38 AND TGF-BETA

ANTI-TGF-BETA ANTIBODIES AND THEIR USE

ANTI-TGF-BETA ANTIBODIES AND THEIR USE